Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

CANDOR trial design: Investigating KdD versus Kd in relapsed/refractory multiple myeloma

Prof Katja Weisel - University Medical Center Hamburg-Eppendorf, Hamburg, Germany
CANDOR trial design: Investigating KdD versus Kd in relapsed/refractory multiple myeloma ( Prof Katja Weisel - University Medical Center Hamburg-Eppendorf, Hamburg, Germany )
13 Jun 2020

GMMG-CONCEPT: Isa-KRd in front-line treatment of high-risk myeloma

Prof Katja Weisel - University Medical Center Hamburg-Eppendorf, Hamburg, Germany
GMMG-CONCEPT: Isa-KRd in front-line treatment of high-risk myeloma ( Prof Katja Weisel - University Medical Center Hamburg-Eppendorf, Hamburg, Germany )
13 Jun 2020

Checkpoint inhibitors for the treatment of advanced hepatocellular carcinoma

Dr Katie Kelley - University of California San Francisco, San Francisco, USA
Checkpoint inhibitors for the treatment of advanced hepatocellular carcinoma ( Dr Katie Kelley - University of California San Francisco, San Francisco, USA )
12 Jun 2020

Updated results from KEYNOTE-426 for metastatic kidney cancer

Dr Elizabeth Plimack - Fox Chase Cancer Center, Philadelphia, USA
Updated results from KEYNOTE-426 for metastatic kidney cancer ( Dr Elizabeth Plimack - Fox Chase Cancer Center, Philadelphia, USA )
12 Jun 2020

METex14 SAs (MET exon 14 skipping alterations) in non-small cell lung cancer

Prof Mark Awad - Dana Farber Cancer Institute, Boston, USA
METex14 SAs (MET exon 14 skipping alterations) in non-small cell lung cancer ( Prof Mark Awad - Dana Farber Cancer Institute, Boston, USA )
12 Jun 2020

ASCO 2020: Breast cancer roundup

Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
ASCO 2020: Breast cancer roundup ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
11 Jun 2020

Perioperative novel systemic immunotherapy-based approaches in urinary cancers

Dr Shilpa Gupta - Cleveland Clinic, Cleveland, USA
Perioperative novel systemic immunotherapy-based approaches in urinary cancers ( Dr Shilpa Gupta - Cleveland Clinic, Cleveland, USA )
9 Jun 2020

Association of BRCA alterations with response to PARP inhibitors in metastatic castration-resistant prostate cancer

Dr Emmanuel Antonarakis - John Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA
Association of BRCA alterations with response to PARP inhibitors in metastatic castration-resistant prostate cancer ( Dr Emmanuel Antonarakis - John Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA )
30 May 2020

COVID-19: Treating breast cancer and the knock on effects of the coronavirus pandemic

Prof Stephen Johnston - Royal Marsden NHS Foundation Trust, London, UK
COVID-19: Treating breast cancer and the knock on effects of the coronavirus pandemic ( Prof Stephen Johnston - Royal Marsden NHS Foundation Trust, London, UK )
28 May 2020

COVID-19: Using oncology drugs and surgery during the coronavirus pandemic

Dr. Paolo Ascierto - Istituto Nazionale Tumori, Milan, Italy
COVID-19: Using oncology drugs and surgery during the coronavirus pandemic ( Dr. Paolo Ascierto - Istituto Nazionale Tumori, Milan, Italy )
21 May 2020

Immune checkpoint based approaches in AML and MDS

Dr Naval Daver - University of Texas MD Anderson Cancer Center, Houston, USA
Immune checkpoint based approaches in AML and MDS ( Dr Naval Daver - University of Texas MD Anderson Cancer Center, Houston, USA )
8 Apr 2020

Testing and treatment for CDH1 in hereditary diffuse gastric cancer and breast cancer

Dr. Geraldo Alves - Hospital Santa Rosa, Brasil
Testing and treatment for CDH1 in hereditary diffuse gastric cancer and breast cancer ( Dr. Geraldo Alves - Hospital Santa Rosa, Brasil )
26 Mar 2020